Predicting amyloid PET positivity using plasma p‐tau181 and other blood‐based biomarkers
Abstract Introduction This study aimed to determine the efficacy of combining plasma phosphorylated tau (p‐tau)181, amyloid beta (Aβ)42/Aβ40, neurofilament light (NfL), and apolipoprotein E (APOE) genotypes for detecting positive amyloid positron emission tomography (PET), which is little known in t...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
Wiley
2023-10-01
|
| Sraith: | Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring |
| Ábhair: | |
| Rochtain ar líne: | https://doi.org/10.1002/dad2.12502 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|